RU2005131943A - Лечебные и/или профилактические средства для хронических болезней кожи - Google Patents
Лечебные и/или профилактические средства для хронических болезней кожи Download PDFInfo
- Publication number
- RU2005131943A RU2005131943A RU2005131943/15A RU2005131943A RU2005131943A RU 2005131943 A RU2005131943 A RU 2005131943A RU 2005131943/15 A RU2005131943/15 A RU 2005131943/15A RU 2005131943 A RU2005131943 A RU 2005131943A RU 2005131943 A RU2005131943 A RU 2005131943A
- Authority
- RU
- Russia
- Prior art keywords
- skin diseases
- chronic skin
- therapeutic
- medicinal
- prophylactic agent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Claims (6)
2. Лечебное и/или профилактическое средство для хронических болезней кожи по п.1, представляющее собой препарат для наружного применения.
4. Способ лечения и/или предупреждения хронических болезней кожи по п.3, отличающийся тем, что вводят препарат для наружного применения.
6. Применение по п.5, где лечебное и/или профилактическое средство для хронических болезней кожи представляет собой препарат для наружного применения.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003071822 | 2003-03-17 | ||
JP2003-071822 | 2003-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2005131943A true RU2005131943A (ru) | 2006-03-20 |
Family
ID=33027707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2005131943/15A RU2005131943A (ru) | 2003-03-17 | 2004-03-17 | Лечебные и/или профилактические средства для хронических болезней кожи |
Country Status (14)
Country | Link |
---|---|
US (1) | US20060173028A1 (ru) |
EP (1) | EP1621196A4 (ru) |
JP (1) | JPWO2004082683A1 (ru) |
KR (1) | KR20050108402A (ru) |
CN (1) | CN1761466A (ru) |
AU (1) | AU2004222432A1 (ru) |
BR (1) | BRPI0408314A (ru) |
CA (1) | CA2519026A1 (ru) |
HR (1) | HRP20050905A2 (ru) |
MX (1) | MXPA05009921A (ru) |
NO (1) | NO20054718L (ru) |
RU (1) | RU2005131943A (ru) |
WO (1) | WO2004082683A1 (ru) |
ZA (1) | ZA200507497B (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006098353A1 (ja) * | 2005-03-15 | 2006-09-21 | Kyowa Hakko Kogyo Co., Ltd. | 外用剤 |
WO2006123726A1 (ja) * | 2005-05-18 | 2006-11-23 | Kyowa Hakko Kogyo Co., Ltd. | 医薬組成物 |
NZ577863A (en) * | 2006-12-22 | 2012-04-27 | Leo Pharma As | Substituted acetophenones useful as pde4 inhibitors |
WO2013030789A1 (en) * | 2011-08-30 | 2013-03-07 | Ranbaxy Laboratories Limited | Pharmaceutical oral solid dosage form containing a poorly water soluble pde - iv inhibitor |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4172817B2 (ja) * | 1995-05-19 | 2008-10-29 | 協和醗酵工業株式会社 | 含酸素複素環化合物 |
US6514996B2 (en) * | 1995-05-19 | 2003-02-04 | Kyowa Hakko Kogyo Co., Ltd. | Derivatives of benzofuran or benzodioxole |
TW555759B (en) * | 1998-06-08 | 2003-10-01 | Darwin Discovery Ltd | Heterocyclic compounds and their therapeutic use |
MY123585A (en) * | 2000-03-23 | 2006-05-31 | Merck Canada Inc | Tri-aryl-substituted-ethane pde4 inhibitors. |
CN1274667C (zh) * | 2001-06-29 | 2006-09-13 | 日研化学株式会社 | 环烯酮衍生物 |
TWI221838B (en) * | 2001-08-09 | 2004-10-11 | Tanabe Seiyaku Co | Pyrazinoisoquinoline compound or naphthalene compound |
DE10205274A1 (de) * | 2002-02-08 | 2003-08-21 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen |
WO2006098353A1 (ja) * | 2005-03-15 | 2006-09-21 | Kyowa Hakko Kogyo Co., Ltd. | 外用剤 |
-
2004
- 2004-03-17 EP EP04721318A patent/EP1621196A4/en not_active Withdrawn
- 2004-03-17 CN CNA2004800071355A patent/CN1761466A/zh active Pending
- 2004-03-17 CA CA002519026A patent/CA2519026A1/en not_active Abandoned
- 2004-03-17 KR KR1020057017352A patent/KR20050108402A/ko not_active Application Discontinuation
- 2004-03-17 RU RU2005131943/15A patent/RU2005131943A/ru not_active Application Discontinuation
- 2004-03-17 US US10/548,639 patent/US20060173028A1/en not_active Abandoned
- 2004-03-17 JP JP2005503713A patent/JPWO2004082683A1/ja not_active Abandoned
- 2004-03-17 MX MXPA05009921A patent/MXPA05009921A/es not_active Application Discontinuation
- 2004-03-17 AU AU2004222432A patent/AU2004222432A1/en not_active Abandoned
- 2004-03-17 WO PCT/JP2004/003554 patent/WO2004082683A1/ja not_active Application Discontinuation
- 2004-03-17 BR BRPI0408314-8A patent/BRPI0408314A/pt not_active IP Right Cessation
-
2005
- 2005-09-16 ZA ZA200507497A patent/ZA200507497B/en unknown
- 2005-10-13 NO NO20054718A patent/NO20054718L/no not_active Application Discontinuation
- 2005-10-17 HR HR20050905A patent/HRP20050905A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0408314A (pt) | 2006-03-07 |
CA2519026A1 (en) | 2004-09-30 |
NO20054718D0 (no) | 2005-10-13 |
NO20054718L (no) | 2005-12-09 |
ZA200507497B (en) | 2007-02-28 |
MXPA05009921A (es) | 2005-11-04 |
CN1761466A (zh) | 2006-04-19 |
KR20050108402A (ko) | 2005-11-16 |
HRP20050905A2 (hr) | 2006-04-30 |
WO2004082683A1 (ja) | 2004-09-30 |
EP1621196A4 (en) | 2007-03-21 |
EP1621196A1 (en) | 2006-02-01 |
JPWO2004082683A1 (ja) | 2006-06-22 |
US20060173028A1 (en) | 2006-08-03 |
AU2004222432A1 (en) | 2004-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR19990044182A (ko) | 말초 활성 통각과민 치료용 아편제 | |
ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
EA200600820A1 (ru) | Способы лечения, модификации и устранения боли с использованием 1-оксо-2-(2,6-диоксопиперидин-3-ил)-4-метилизоиндолина | |
JP2006501240A5 (ru) | ||
EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
RU2004135563A (ru) | Лекарственное средство для лечения повышенной активности мочевого пузыря | |
SE9901573D0 (sv) | New compounds | |
RU2006131553A (ru) | Комбинация(а) ингибитора топоизомеразы днк и (б) ингибитора iap | |
JP2002528502A5 (ru) | ||
RU2006139819A (ru) | Применение симетикона для предрасположенных к запорам пациентов | |
JP2004537500A5 (ru) | ||
CA2313270A1 (en) | Use of deferiprone in treating and preventing iron-induced cardiac disease | |
RU2004131214A (ru) | Способы лечения когнитивных расстройств | |
WO2009003694A3 (en) | Method for treating diseases related to mitochondrial dysfunction | |
WO2001012214A3 (en) | MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a) | |
RU2001118854A (ru) | Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний | |
WO1998030223B1 (en) | Cytokine related treatments of disease | |
RU2007117492A (ru) | Применение органических соединений | |
RU2005131943A (ru) | Лечебные и/или профилактические средства для хронических болезней кожи | |
SE9901572D0 (sv) | New compounds | |
RU2005135647A (ru) | Комбинации, включающие пароксетин и {1-(r)-(3.5-бис-трифтор-2-метилфенил) этилметиламид}-2-(s)-(4-фтор-2-метилфенил) пиперазин-1-карбоновой кислоты, для лечения депрессии и/или тревоги | |
ATE333897T1 (de) | Arzneimittel mit chymaseinhibitoren als wirksames mittel zur behandlung von dermatitis mit zweiphasigen hautreaktionen | |
RU2006101061A (ru) | Азенапин для лечения шизофрении у пациентов с избыточной массой тела или предрасположенностью к избыточной массе тела | |
JP2004524270A (ja) | 長時間作用する麻酔薬および鎮痛薬としての、三環式抗うつ薬およびのそれらのアナログ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20080523 |